Registro:

Referencias:

• Dekel, N., Gnainsky, Y., Granot, I., Mor, G., Inflammation and implantation (2010) Am. J. Immunol., 63, pp. 17-21
• Weiss, G., Goldsmith, L.T., Taylor, R.N., Bellet, D., Taylor, H.S., Inflammation in reproductive disorders (2009) Reprod Sciences, 16, pp. 216-229
• Gomez-Lopez, N., Guilbert, L.J., Olson, D.M., Invasion of the leukocytes into the fetal-maternal interface during pregnancy (2010) J. Leuk. Biol., 88, pp. 625-633
• Mor, G., Cardenas, I., The immune system in pregnancy: A unique complexity (2010) Am. J. Reprod. Immunol., 63, pp. 425-433
• Nagamatsu, T., Schust, D.J., The contribution of macrophages to normal and pathological pregnancies (2010) Am. J. Reprod. Immunol., 63, pp. 460-471
• Salamone, G., Trophoblast cells induce a tolerogenic profile in dendritic cells (2012) Hum. Reprod., 27, pp. 2598-2606
• Teles, A., Origin of Foxp3(+) cells during pregnancy (2013) Am J Clin Exp Immuno, 2, pp. 222-233
• Pérez Leirós, C., Ramhorst, R., Tolerance induction at the early maternal-placental interface through selective cell recruitment and targeting by immune polypeptides (2013) Am. J. Reprod. Immunol., 69, pp. 359-368
• Yoshinaga, K., Progesterone and Its Downstream Molecules as Blastocyst Implantation Essential Factors (2014) Am. J. Reprod. Immunol., 4, pp. 117-128
• Robertson, S.A., Prins, J.R., Sharkey, D.J., Moldenhauer, L.M., Seminal fluid and the generation of regulatory T cells for embryo implantation (2013) Am. J. Reprod. Immunol., 69, pp. 315-330
• Fraccaroli, L., Defects in the vasoactive intestinal peptide (VIP)/VPAC system during early stages of the placental-maternal leucocyte interaction impair the maternal tolerogenic response (2012) Clin. Exp. Immunol., 170, pp. 310-320
• Hauk, V., Vasoactive intestinal peptide induces an immunosuppressant microenvironment in the maternal-fetal interface of non-obese diabetic mice and improves early pregnancy outcome (2014) Am .J. Reprod. Immunol., 71, pp. 120-130
• Santner-Nanan, B., Systemic increase in the ratio between Foxp3+ and IL-17-producing CD4+ T cells in healthy pregnancy but not in preeclampsia (2009) J. Immunol., 183, pp. 7023-7030
• D'Addio, F., The link between the PDL1 costimulatory pathway and Th17 in fetomaternal tolerance (2011) J Immunol., 1, pp. 4530-4541
• Abad, C., Tan, Y.V., Cheung-Lau, G., Nobuta, H., Waschek, J.A., VIP deficient mice exhibit resistance to lipopolysaccharide induced endotoxemia with an intrinsic defect in proinflammatory cellular responses (2012) PLoS One, 7
• Mjosberg, J., Berg, G., Jenmalm, M.C., Ernerudh, J., FOXP3+ regulatory T cells and T helper 1, T helper 2, and T helper 17 cells in human early pregnancy decidua (2009) Biol. Reprod., 82, pp. 698-705
• Mantovani, A., Biswas, S.K., Galdiero, M.R., Sica, A., Locati, M., Macrophage plasticity and polarization in tissue repair and remodelling (2013) J Pathol., 229, pp. 176-185
• Fest, S., Trophoblast-macrophage interactions: A regulatory network for the protection of pregnancy (2007) Am J Reprod Immunol., 57, pp. 55-66
• Delgado, M., Munoz-Elias, E.J., Gomariz, R.P., Ganea, D., Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide prevent inducible nitric oxide synthase transcription in macrophages by inhibiting NF-kappa B and IFN regulatory factor 1 activation (1999) J. Iimmunol, 162, pp. 4685-4696
• Gomariz, R.P., Regulation of TLR expression, a new perspective for the role of VIP in immunity (2007) Peptides, 28, pp. 1825-1832
• Gonzalez-Rey, E., Anderson, P., Delgado, M., Emerging roles of vasoactive intestinal peptide: A new approach for autoimmune therapy (2007) Annals Rheum. Dis., 66, pp. iii70-iii76
• Jimeno, R., Effect of VIP on the balance between cytokines and master regulators of activated helper T cells (2012) Immunol. Cell Biol., 90, pp. 178-186
• Roca, V., Potential immunomodulatory role of VIP in the implantation sites of prediabetic nonobese diabetic mice (2009) Reproduction, 138, pp. 733-742
• Zenclussen, A.C., Abnormal T-cell reactivity against paternal antigens in spontaneous abortion: Adoptive transfer of pregnancy-induced CD4+CD25+ T regulatory cells prevents fetal rejection in a murine abortion model (2005) Am. J. Pathol., 166, pp. 811-822
• Clark, D.A., Chaouat, G., Arck, P.C., Mittruecker, H.W., Levy, G.A., Cytokine-dependent abortion in CBA x DBA/2 mice is mediated by the procoagulant fgl2 prothrombinase (1998) J. Immunol., 15, pp. 545-549
• Girardi, G., Yarilin, D., Thurman, J.M., Holers, V.M., Salmon, J.E., Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction (2006) J. Exp. Med., 203, pp. 2165-2175
• Bouhlel, M.A., PPARgamma activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties (2007) Cell Metab., 6, pp. 137-143
• Odegaard, J.I., Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance (2007) Nature, 447, pp. 1116-1120
• Racicot, K., Kwon, J.-Y., Aldo, P., Silasi, M., Mor, G., Understanding the Complexity of the Immune System during Pregnancy (2014) Am. J. Reprod. Immunol., 72, pp. 107-116
• Roca, V., Reduced nitric oxide synthase and cyclo-oxygenase activity in the uterus of non-obese diabetic mice (2006) Reproduction, 132, pp. 931-938
• Obermajer, N., Conversion of Th17 into IL-17A(neg) regulatory T cells: A novel mechanism in prolonged allograft survival promoted by mesenchymal stem cell-supported minimized immunosuppressive therapy (2014) J.Immunol., 193, pp. 4988-4999
• Chen, Q., Navigating the site for embryo implantation: Biomechanical and molecular regulation of intrauterine embryo distribution (2013) Mol. Asp. Med., 34, pp. 1024-1042
• Schif-Zuck, S., Saturated-efferocytosis generates pro-resolving CD11b low macrophages: Modulation by resolvins and glucocorticoids (2011) Eur. J. Immunol., 41, pp. 366-379. , A
• Fernandez-Boyanapalli, R., PPARgamma activation normalizes resolution of acute sterile inflammation in murine chronic granulomatous disease (2010) Blood, 116, pp. 4512-4522
• Fernandez-Boyanapalli, R.F., Impaired apoptotic cell clearance in CGD due to altered macrophage programming is reversed by phosphatidylserine-dependent production of IL-4 (2009) Blood, 113, pp. 2047-2055
• Korns, D., Frasch, S.C., Fernandez-Boyanapalli, R., Henson, P.M., Bratton, D.L., Modulation of macrophage efferocytosis in inflammation (2011) Fron.Immunol., 2, p. 57
• Pang, S., (2014) The Guide to Investigation of Mouse Pregnancy, pp. 21-42. , (ed. Croy, A.) Elsevier Inc
• Larocca, L., Modulation of macrophage inflammatory profile in pregnant nonobese diabetic (NOD) mice (2011) Mol. Cell. Endocrinol., 333, pp. 112-118

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------